Business Context and Reporting Period
AMCON Distributing Company, a consumer products distributor based in Omaha, NE, filed this Form 8-K on August 11, 2003, to report financial results for the third quarter and nine months ended June 27, 2003. The company operates wholesale distribution centers across six states and manages retail health food stores and a beverage division (Hawaiian Natural Water).
Key Financial Metrics
| Metric | Q3 2003 | Q3 2002 | 9 Months 2003 | 9 Months 2002 |
|---|---|---|---|---|
| Sales | $189.9 million | $218.7 million | $564.7 million | $623.0 million |
| Net Income | $690,805 | $842,593 | $691,993 | $1,323,671 |
| Diluted EPS | $0.22 | $0.26 | $0.22 | $0.43 |
| Gross Profit | $16.0 million | $16.1 million | $43.7 million | $45.4 million |
| Operating Income | $1.8 million | $2.4 million | $3.2 million | $5.2 million |
| Cash and Equivalents | $581,216 | $130,091 | Balance Sheet Data | |
| Total Debt (Current + Long-term) | $40.8 million | $51.6 million |
Liquidity and Margins: Cash flow from operations increased by over $17 million year-to-date. The company reduced its operating line usage to approximately 51% of availability and locked in interest costs for half of its credit line usage below 5%. Gross margins remained relatively flat in the quarter but declined slightly on a year-to-date basis due to sales mix changes.
Material Changes vs. Prior Period
- Revenue Decline: Sales dropped 13.2% in Q3 and 9.4% for the nine-month period. The wholesale segment saw a 12.2% decline in cigarette carton volume due to deflationary price trends and a consumer shift toward value-priced brands where AMCON has limited market share.
- Earnings Pressure: Net income decreased 18% in Q3 and 48% for the nine-month period. Key headwinds included the absence of a cigarette price increase, reduced private label earnings, and lower manufacturer incentive allowances, totaling $1.9 million less in Q3 and $2.9 million less for the nine months compared to the prior year.
- Offsetting Factors: Negative impacts were partially offset by favorable LIFO inventory adjustments ($1.2 million in Q3, $1.1 million for nine months), increased profits from non-cigarette products, and reduced operating and interest expenses.
- Debt Reduction: Total debt decreased significantly from $51.6 million (Sept 2002) to $40.8 million (June 2003), driven by improved cash flow in the wholesale segment.
Guidance, Outlook, and Risks
Management Commentary: Chairman William F. Wright highlighted a dramatic improvement in pre-tax profit and cash flow within the wholesale segment, with pre-tax net income up over 28% despite the sales drop. The retail health segment is improving under new management with integrated systems. The beverage segment (Hawaiian Natural Water) is currently consuming significant earnings due to startup costs for The Beverage Group, including marketing and facility construction, but management expects it to eventually produce profits and increase overall margins.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Specific risks cited include competitive factors in the tobacco market, consumer shifts to value brands, and the uncertainty of the beverage segment's profitability timeline. The company noted that expenditures for the beverage expansion are expensed as incurred, impacting current earnings.
Investor Verification Checklist
- Cigarette Volume Trends: Verify the sustainability of the 12.2% decline in cigarette carton volume and the impact of deflationary pricing on future wholesale margins.
- Beverage Segment Burn Rate: Assess the timeline for The Beverage Group to reach profitability and the magnitude of ongoing capital and marketing expenditures.
- LIFO Adjustments: Confirm the sustainability of the favorable LIFO inventory adjustments ($1.2M Q3, $1.1M YTD) which significantly offset operating losses.
- Debt Covenants: Review the terms of the locked-in interest rates and the remaining capacity on the operating line to ensure liquidity remains sufficient for expansion plans.
- Private Label Performance: Investigate the specific causes of reduced earnings from private label products and whether this trend is expected to reverse.